Hbk Sorce Advisory LLC Intellia Therapeutics, Inc. Transaction History

Hbk Sorce Advisory LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$58.27 - $118.99 $249,920 - $510,348	-4,289 Closed	0 $0
Q4 2021 Feb 15, 2022	SELL	$100.76 - $138.36 $13,602 - $18,678	-135 Reduced 3.05%	4,289 $507,000
Q3 2021 Nov 15, 2021	SELL	$132.37 - $176.78 $6,089 - $8,131	-46 Reduced 1.03%	4,424 $593,000
Q2 2021 Aug 12, 2021	BUY	$60.88 - $161.91 $120,298 - $319,934	1,976 Added 79.23%	4,470 $724,000
Q1 2021 May 14, 2021	BUY	$46.59 - $83.68 $116,195 - $208,697	2,494 New	2,494 $200,000
Q1 2019 May 13, 2019	SELL	$12.79 - $17.62 $132,593 - $182,666	-10,367 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$11.39 - $27.13 $7,517 - $17,905	660 Added 6.8%	10,367 $142,000
Q3 2018 Nov 15, 2018	BUY	$25.78 - $32.6 $54,808 - $69,307	2,126 Added 28.04%	9,707 $278,000
Q2 2018 Aug 10, 2018	BUY	$20.02 - $30.79 $151,771 - $233,418	7,581 New	7,581 $0

313

91.5M

442K

880K

Ticker NTLA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,011,800
Market Cap $997M
Description
Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...

Get notified when there are updates to the investment portfolio of Hbk Sorce Advisory LLC, based on Form 13F filings with the SEC.

Stay updated on Hbk Sorce Advisory LLC with notifications on news.